Li Y, Jie C, Wang J, Zhang W, Wang J, Deng Y
Medicine (Baltimore). 2024; 103(25):e38596.
PMID: 38905408
PMC: 11191902.
DOI: 10.1097/MD.0000000000038596.
Boscia G, Pozharitskiy N, Grassi M, Borrelli E, Daddario M, Alessio G
Sci Rep. 2024; 14(1):1941.
PMID: 38253789
PMC: 10803349.
DOI: 10.1038/s41598-024-52315-w.
Interlenghi M, Sborgia G, Venturi A, Sardone R, Pastore V, Boscia G
Diagnostics (Basel). 2023; 13(18).
PMID: 37761333
PMC: 10528426.
DOI: 10.3390/diagnostics13182965.
Viggiano P, Grassi M, Boscia G, Pignataro M, Petruzzella G, Borrelli E
J Clin Med. 2022; 11(19).
PMID: 36233385
PMC: 9570643.
DOI: 10.3390/jcm11195517.
Guillemette S, Rico C, Godin P, Boerboom D, Paquet M
J Mammary Gland Biol Neoplasia. 2017; 22(3):203-214.
PMID: 28822004
DOI: 10.1007/s10911-017-9384-9.
Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).
Chan C, Jain A, Sadda S, Varshney N
Trans Am Ophthalmol Soc. 2015; 112:160-98.
PMID: 25646034
PMC: 4307397.
Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series.
Cardascia N, Furino C, Ferrara A, Boscia F, Alessio G
Curr Ther Res Clin Exp. 2014; 70(3):240-51.
PMID: 24683234
PMC: 3967339.
DOI: 10.1016/j.curtheres.2009.05.001.
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.
Fong A, Lai T
Clin Interv Aging. 2013; 8:467-83.
PMID: 23766636
PMC: 3677930.
DOI: 10.2147/CIA.S36811.
Radiotherapy for neovascular age-related macular degeneration.
Evans J, Sivagnanavel V, Chong V
Cochrane Database Syst Rev. 2010; (5):CD004004.
PMID: 20464726
PMC: 7163277.
DOI: 10.1002/14651858.CD004004.pub3.
Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?.
Ghazi N, Conway B, Tiedeman J, Yoon S
Clin Ophthalmol. 2009; 2(4):773-80.
PMID: 19668430
PMC: 2699805.
DOI: 10.2147/opth.s3653.
Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.
Krebs I, Krepler K, Stolba U, Goll A, Binder S
Graefes Arch Clin Exp Ophthalmol. 2007; 246(2):237-43.
PMID: 17674018
DOI: 10.1007/s00417-007-0651-0.
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
Schadlu R, Kymes S, Apte R
Graefes Arch Clin Exp Ophthalmol. 2007; 245(11):1667-72.
PMID: 17583819
DOI: 10.1007/s00417-007-0619-0.
Prognosis of untreated occult choroidal neovascularization.
Krebs I, Stolba U, Glittenberg C, Seyeddain O, Benesch T, Binder S
Graefes Arch Clin Exp Ophthalmol. 2006; 245(3):376-84.
PMID: 17072636
DOI: 10.1007/s00417-006-0424-1.
A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.
Wickens J, Blinder K
Drug Saf. 2006; 29(3):189-99.
PMID: 16524319
DOI: 10.2165/00002018-200629030-00003.
Current and future treatment options for nonexudative and exudative age-related macular degeneration.
Comer G, Ciulla T, Criswell M, Tolentino M
Drugs Aging. 2005; 21(15):967-92.
PMID: 15631528
DOI: 10.2165/00002512-200421150-00002.
Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.
Ciulla T, Criswell M, Snyder W, Small 4th W
Br J Ophthalmol. 2004; 89(1):113-9.
PMID: 15615758
PMC: 1772484.
DOI: 10.1136/bjo.2004.043075.
[Photodynamic therapy in AMD. Strategy for indication].
Pauleikhoff D, Spital G
Ophthalmologe. 2004; 101(12):1224-30.
PMID: 15480699
DOI: 10.1007/s00347-004-1119-9.
Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes.
van Meurs J, ter Averst E, Hofland L, van Hagen P, Mooy C, Baarsma G
Br J Ophthalmol. 2003; 88(1):110-3.
PMID: 14693786
PMC: 1771957.
DOI: 10.1136/bjo.88.1.110.
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
Keam S, Scott L, Curran M
Drugs. 2003; 63(22):2521-54.
PMID: 14609361
DOI: 10.2165/00003495-200363220-00016.
